Glenmark to conduct Phase III trial nasal spray meant to treat Covid-19

​Glenmark has joined hands with the Canadian company named Sanotize. The nasal spray works by killing the virus largely in the upper airways, preventing it from spreading to the lungs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hGKRS7
via IFTTT